• Documents
  • Authors
  • Tables
  • Log in
  • Sign up
  • MetaCart
  • DMCA
  • Donate

CiteSeerX logo

Tools

Sorted by:
Try your query at:
Semantic Scholar Scholar Academic
Google Bing DBLP
Results 1 - 10 of 61
Next 10 →

doi:10.1093/nar/gkq929 COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer

by Simon A. Forbes, Nidhi Bindal, Sally Bamford, Charlotte Cole, Chai Yin Kok, David Beare, Mingming Jia, Rebecca Shepherd, Kenric Leung, Andrew Menzies, Jon W. Teague, Peter J. Campbell, Michael R. Stratton, P. Andrew Futreal , 2010
"... COSMIC ..."
Abstract - Add to MetaCart
COSMIC

The COSMIC (Catalogue of Somatic Mutations in Cancer) database and website

by S Bamford, E Dawson, S Forbes, J Clements, R Pettett, A Dogan, A Flanagan, J Teague, Pa Futreal, Mr Stratton, R Wooster - Br J Cancer , 2004
"... The discovery of mutations in cancer genes has advanced our understanding of cancer. These results are dispersed across the scientific literature and with the availability of the human genome sequence will continue to accrue. The COSMIC (Catalogue of Somatic Mutations in Cancer) database and website ..."
Abstract - Cited by 65 (0 self) - Add to MetaCart
The discovery of mutations in cancer genes has advanced our understanding of cancer. These results are dispersed across the scientific literature and with the availability of the human genome sequence will continue to accrue. The COSMIC (Catalogue of Somatic Mutations in Cancer) database

Original article Data mining using the Catalogue of Somatic Mutations in Cancer BioMart

by Rebecca Shepherd, Simon A. Forbes, David Beare, S. Bamford, Charlotte G. Cole, Sari Ward, Nidhi Bindal, Prasad Gunasekaran, Mingming Jia, Chai Yin Kok, Kenric Leung, Andrew Menzies, Adam P. Butler, Jon W. Teague, Peter J. Campbell, Michael R. Stratton, P. Andrew Futreal
"... providing information on somatic mutations implicated in human cancer. Release v51 (January 2011) includes data from just over 19 000 genes, 161 787 coding mutations and 5573 gene fusions, described in more than 577 000 tumour samples. COSMICMart (COSMIC BioMart) provides a flexible way to mine thes ..."
Abstract - Add to MetaCart
providing information on somatic mutations implicated in human cancer. Release v51 (January 2011) includes data from just over 19 000 genes, 161 787 coding mutations and 5573 gene fusions, described in more than 577 000 tumour samples. COSMICMart (COSMIC BioMart) provides a flexible way to mine

Cancer Genome Consortium, and publicly available catalogs such as the Catalogue of Somatic Mutations in Cancer and

by unknown authors
"... Advances in diagnostics and targeted therapies during the pastdecadehavechangedhowoncology is viewed. “Stratified medicine ” has emerged from the accumulated evidence gar-nered frommatching targeted therapies with tumor molecu-lar aberrations. Concomitantly, current knowledge derived from large-scal ..."
Abstract - Add to MetaCart
Advances in diagnostics and targeted therapies during the pastdecadehavechangedhowoncology is viewed. “Stratified medicine ” has emerged from the accumulated evidence gar-nered frommatching targeted therapies with tumor molecu-lar aberrations. Concomitantly, current knowledge derived from large-scale, massively parallel sequencing technologies

Cancer Genome Consortium, and publicly available catalogs such as the Catalogue of Somatic Mutations in Cancer and

by unknown authors
"... Advances in diagnostics and targeted therapies during the pastdecadehavechangedhowoncology is viewed. “Stratified medicine ” has emerged from the accumulated evidence gar-nered frommatching targeted therapies with tumor molecu-lar aberrations. Concomitantly, current knowledge derived from large-scal ..."
Abstract - Add to MetaCart
Advances in diagnostics and targeted therapies during the pastdecadehavechangedhowoncology is viewed. “Stratified medicine ” has emerged from the accumulated evidence gar-nered frommatching targeted therapies with tumor molecu-lar aberrations. Concomitantly, current knowledge derived from large-scale, massively parallel sequencing technologies

Editorial The continuing search for cancer-causing somatic mutations

by Gillian L Dalgliesh, P Andrew Futreal , 2007
"... It is known that cancer is caused by an accumulation of mutations in DNA. Many genes have been associated with tumour progression either through germline or somatic mutations, but mutations in these genes by no means account for all instances of the disease. The availability of the completed human g ..."
Abstract - Add to MetaCart
It is known that cancer is caused by an accumulation of mutations in DNA. Many genes have been associated with tumour progression either through germline or somatic mutations, but mutations in these genes by no means account for all instances of the disease. The availability of the completed human

PROCEEDINGS Open Access Somatic mutations in cancer development

by Lucio Luzzatto , 2009
"... The transformation of a normal cell into a cancer cell takes place through a sequence of a small number of discrete genetic events, somatic mutations: thus, cancer can be regarded properly as a genetic disease of somatic cells. The analogy between evolution of organisms and evolution of cell populat ..."
Abstract - Add to MetaCart
The transformation of a normal cell into a cancer cell takes place through a sequence of a small number of discrete genetic events, somatic mutations: thus, cancer can be regarded properly as a genetic disease of somatic cells. The analogy between evolution of organisms and evolution of cell

Integrative genomic analysis reveals somatic mutations in pheochromocytoma and

by Nelly Burnichon , Laure Vescovo , Laurence Amar , Rossella Libé , Auré Lien De Reynies , Annabelle Venisse , Elodie Jouanno , Ingrid Laurendeau , Bé Atrice Parfait , Jé Rô Me Bertherat , Pierre-Franç Ois Plouin , Xavier Jeunemaitre , Judith Favier , Anne-Paule Gimenez-Roqueplo , 2011
"... Pheochromocytomas and paragangliomas are neuroendocrine tumors that occur in the context of inherited cancer syndromes in ∼30% of cases and are linked to germline mutations in the VHL, RET, NF1, SDHA, SDHB, SDHC, SDHD, SDHAF2 and TMEM127 genes. Although genome-wide expression studies have revealed ..."
Abstract - Cited by 5 (3 self) - Add to MetaCart
investigated 202 pheochromocytomas/paragangliomas, including 75 hereditary tumors, using expression profiling, BAC array comparative genomic hybridization and somatic mutation screening. Gene expression signatures defined the hereditary tumors according to their genotype and notably, led to a complete

H (2013) Identification of candidate genes for lung cancer somatic mutation test kits. Genetics and molecular biology 36(3): 455–464. doi: 10.1590/S141547572013000300022 PMID: 24130455

by Yong Chen, Jian-xin Shi, Xu-feng Pan, Jian Feng, Heng Zhao
"... Over the past three decades, mortality from lung cancer has sharply and continuously increased in China, ascending to the first cause of death among all types of cancer. The ability to identify the actual sequence of gene mutations may help doctors determine which mutations lead to precancerous lesi ..."
Abstract - Cited by 1 (0 self) - Add to MetaCart
lesions and which produce invasive carcinomas, especially using next-generation sequencing (NGS) technology. In this study, we analyzed the latest lung cancer data in the COSMIC database, in order to find genomic “hotspots ” that are frequently mutated in human lung cancer genomes. The results revealed

CancerGenes: a gene selection resource for cancer genome projects

by Maureen E. Higgins, Martine Claremont, John E. Major, Chris S, Alex E. Lash - Nucl. Acids Res , 2007
"... The genome sequence framework provided by the human genome project allows us to precisely map human genetic variations in order to study their association with disease and their direct effects on gene function. Since the description of tumor suppressor genes and oncogenes several decades ago, both g ..."
Abstract - Cited by 47 (0 self) - Add to MetaCart
germ-line variations and somatic mutations have been established to be important in cancer—in terms of risk, oncogenesis, prognosis and response to therapy. The Cancer Genome Atlas initiative proposed by the NIH is poised to elucidate the contribution of somatic mutations to cancer development
Next 10 →
Results 1 - 10 of 61
Powered by: Apache Solr
  • About CiteSeerX
  • Submit and Index Documents
  • Privacy Policy
  • Help
  • Data
  • Source
  • Contact Us

Developed at and hosted by The College of Information Sciences and Technology

© 2007-2019 The Pennsylvania State University